Covered recipient · General Payments record
JESSE FRYE
General Payments · PY2022–2025
$1,309.06
- Reported across 41 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $407.47 | 8 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABIOMED | $147.91 | 1 |
| Actelion Pharmaceuticals US, Inc. | $109.90 | 2 |
| Medtronic, Inc. | $94.84 | 2 |
| Acerta Pharma LLC | $21.70 | 1 |
| CHIESI USA, INC. | $18.81 | 1 |
| E.R. Squibb & Sons, L.L.C. | $14.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (8)
Sorted by paying entity, then date · as published by CMS
Program year 2025 202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABIOMED | $147.91 | 04/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174837104 | CMS |
| Actelion Pharmaceuticals US, Inc. | $86.02 | 03/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174266533 | CMS |
| Actelion Pharmaceuticals US, Inc. | $23.88 | 04/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174265905 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.70 | 08/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214789422 | CMS |
| Chiesi USA, Inc. | $18.81 | 08/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242159409 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.31 | 04/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184962445 | CMS |
| Medtronic, Inc. | $48.76 | 03/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1220047749 | CMS |
| Medtronic, Inc. | $46.08 | 04/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1220047751 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.